The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): meeting highlights. 11-13 November, 2009, Dublin, Ireland.
The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD) was organized to support the translation of basic research achievements into clinical practice and to bridge the gap between academic studies and innovations of pharmacologic companies. A clear discrepancy between high rates of immune anti-tumor responses and poor clinical effects makes necessary to improve cancer vaccination. This challenge stimulated a fruitful discussion on strategies of immunization, adjuvants, delivery systems, novel antigens, targets and monitoring of the immune response.
Umansky
Viktor
V
D000276:Adjuvants, Immunologic; D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000627:therapeutic use; D015510:Clinical Medicine / Q000639:trends; D005544:Forecasting; D006801:Humans; D007114:Immunization; D016219:Immunotherapy, Adoptive; D051379:Mice; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D057170:Translational Research, Biomedical / Q000639:trends; D019444:Vaccines, DNA / Q000627:therapeutic use
D000276:Adjuvants, Immunologic; D000951:Antigens, Neoplasm; D019496:Cancer Vaccines; D019444:Vaccines, DNA